Ajay Duseja
@ajay_duseja
Followers
4K
Following
27K
Media
171
Statuses
2K
Professor & Head of Hepatology, Secretary General, Indian National Association for Study of the Liver (INASL). Tweets are personal.
PGIMER, Chandigarh, India
Joined August 2021
📴📰CRRT in Acute Liver Failure - Rationale,Evidence,Practice -Beyond Kidneys -Real world issues With @AnandVKulkarni2
@ajay_duseja @docMPK @MaiwallRakhi @drnipunverma @drshalimar @RobertFontanaMD @ebtapper @RohitMehtaniDM @JasmohanBajaj 👇🏽Check out now
jcehepatology.com
Acute liver failure (ALF) is a life-threatening condition hallmarked by an acute onset of liver dysfunction, coagulopathy, and encephalopathy in individuals without pre-existing liver disease....
3
6
17
Heartiest congratulations Susana @RodriguesSu24 Well deserved title.
Big congratulations to my dear colleague and friend Susana Rodrigues for receiving the academic title of Privat Dozentin at the University of Bern. Our group is so proud of you!
0
0
3
🪔On this auspicious occasion of Diwali We are thrilled to announce the Bengal Liver Summit 2026! 📅 8–10 January 2026 📍 ITC Royal Bengal, Kolkata 🎯 Theme: Acute Complications in Liver Disease 🌍 12 International 🇮🇳 100+ National Faculties Stay tuned for more updates! #BLS2026
2
8
21
Advance Hepatology with JCEH 📊 Impact Factor: 3.2 📈 CiteScore: 5.1 ⏱️ Editorial decision: ~4.9 days ⚡ Online publication: ~4.9 days post-acceptance 📢 Now inviting high-impact liver research. 📝 Submit today 👇🏽 https://t.co/2E4qyL96mQ
@AnandVKulkarni2 @docMPK @ajay_duseja
1
11
27
New @JCEH_Hepatology 🚨 🕐-restricted eating (TRE) supercharges insulin sensitivity in MASLD! 🥗⏰🔥 📊 TRE+Hypocaloric(HCD) vs HCD 🩺 HOMA-IR drop 2.6(TRE+HCD) vs 1.5(HCD) 🛠️ Steatosis 66.7% (TRE+HCD) vs 52.4%(HCD) @ajay_duseja @doc_arka @DrAshish_Kumar
jcehepatology.com
Insulin resistance is a key pathogenic mechanism in metabolic dysfunction-associated steatohepatitis (MASLD). Time-restricted eating (TRE) has the potential to restore insulin sensitivity in patients...
1
3
8
@DivyaKumar182 @ajay_duseja @INASL_Liver Glad to initiate and lead this with my amazing team members- Sukriti and Divya!
0
1
2
Grateful to my mentors @drnipunverma Dr Virendra Singh @ajay_duseja @drsuniltaneja and @HepatologyPGI for guidance, and nurturing environment that shaped my PhD journey. Relentless work, setbacks, breaking and rebuilding stronger. Thankful for every hand that held me up. 🙏✨
🎓✨ Proud Moment! Our PhD student @pinderbrar888 , has successfully defended her thesis in the public viva with flying colors! 🌟👏 A milestone for her and our team. 🚀💡 Huge gratitude to super mentors @ajay_duseja @drsuniltaneja drvirendrasingh @RajivJalan1
@INASL_Liver
0
1
10
🎓✨ Proud Moment! Our PhD student @pinderbrar888 , has successfully defended her thesis in the public viva with flying colors! 🌟👏 A milestone for her and our team. 🚀💡 Huge gratitude to super mentors @ajay_duseja @drsuniltaneja drvirendrasingh @RajivJalan1
@INASL_Liver
3
3
23
I’m deeply honored to be appointed as Secretary General of @WorldGastroOrg I aim to: ✨Strengthen, expand, & build global collabs with education & mentorship Serving as a global leader is a privilege. Together, we can advance GI care, knowledge, & equity in global digestive
44
24
194
🚨 Just out in @HEP_Journal From 🌍 POCUS👸🏽 @docMPK POCUS 🎯volume management in AKI 💔 CCM 🔑determinant of outcomes 🔸3/4 with HRS have it 🧠 Dynamic, tailored 💦strategy improves AKI 📉 CCM = 8.9× ↑ ⚰️ @AnandVKulkarni2 @drnipunverma @ajay_duseja ⏬
journals.lww.com
and survival, in cirrhosis and AKI between January 2023 and November 2024. Exclusions were patients with structural cardiac disease, portopulmonary hypertension, acute variceal bleeding, and septic...
1
2
14
Incredible honour to be invited as a speaker among experts at #stc @APASLnews in Moscow. #WomenInGi
@AmCollegeGastro @WorldGastroOrg @WomenInGI @EASLnews @AASLDtweets
2
1
13
‘Point-of-Care Ultrasound (POCUS) guided volume management... : Hepatology https://t.co/c63bvQA9VZ Now online. #livertwitter @ajay_duseja @drnipunverma @AnandVKulkarni2 @hepocus @Florent_Artru @manhalizzy @ebtapper POCUS to classify volume status in Cirrhosis & AKI Trajectory
5
26
62
Day 2 kicked off with lively roundtables on EndoHepatology innovations, new MASLD therapeutics, and striking pathology–radiology spotters. Fresh evidence, sharper questions, and a collaborative buzz set the pace for the day. Key Takeaways * Advanced endoscopy = safer, more
1
4
9
AIG Crystal Awards- a recognition for the huge contributions made by the giants in Hepatology @ArunJSanyalVCU Prof Paolo Angeli and Prof @ajay_duseja @VCU_Liver @HepatologyPGI @salvatore_piano #AIGLiverConclave
Shining a spotlight on excellence! The AIG Crystal Awards honored those whose dedication and innovation light the way forward in hepatology. Congratulations to every AIG Crystal Award winner for raising the bar in liver care. #AIGLiverConclave #LiverHealth #AIGHospitals
1
2
22
Shining a spotlight on excellence! The AIG Crystal Awards honored those whose dedication and innovation light the way forward in hepatology. Congratulations to every AIG Crystal Award winner for raising the bar in liver care. #AIGLiverConclave #LiverHealth #AIGHospitals
1
5
28
Humbled to receive the AIG-Crystal-Distinguished Leadership Award Thanks to @DrDNReddy @gvraoaig, Dr PN Rao, Dr Mithun, @AnandVKulkarni2
@manasa_alla and AIG team @AIGHospitals Owe it to my family @RitambhraN, department @HepatologyPGI, Institute @dpgi_chandigarh and @INASL_Liver
12
10
41
https://t.co/MoR7gDspDi Should cirrhosis decompensation be classified in phenotypes ? @EASLnews @INASL_Liver @APASLnews @BASLedu @RajivJalan1 @ReibergerThomas @BavenoCoop @ProfPaoloAngeli @RoyAHep @AnandVKulkarni2 @AASLDtweets @ef_clif @ajay_duseja @drsuniltaneja @SahajRathi
4
23
64
Packed Morning Sessions #AIGLiverConclave
#MajaThiele @EASLnews Fantastic deliberation on MetALD @AnandVKulkarni2 @docMPK @ajay_duseja @manasa_alla
@drnipunverma @INASL_Liver
1
2
20